Insud Pharma
Julia P. is a seasoned entrepreneur with significant experience in the equine and remodeling industries. As the Founder of Intuitive HorseWare since April 2023, Julia P. leverages computer vision and AI technology to enhance horse welfare by detecting early signs of pain. Previously, Julia P. founded Integrity Horse, demonstrating a strong commitment to entrepreneurial values. Additionally, Julia P. worked as an Independent Contractor from April 2016 to November 2021, managing residential remodeling projects, and contributed to account management and project management as a Sales Associate at Reier Group from September 2014 to December 2015. Julia P. holds a degree from Rasmussen University and embodies determination, purpose, and resourcefulness in professional endeavors.
This person is not in the org chart
This person is not in any offices
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.